Hypersensitivity to oxaliplatin: clinical features and risk factors.
about
Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancerAn albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.Hypersensitivity reactions associated with oxaliplatin and their clinical management.Platinum hypersensitivity and desensitization.Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
P2860
Q33600062-D7F4B424-EAC1-4D68-AC49-735B6AD9C70EQ33615268-937D7BFB-E201-461E-AF17-05DB35F4D8E0Q36288948-BE19C07C-7040-485D-BED2-472C9B5FD624Q38222050-2B53EE28-CAF1-4509-9BA4-C992B56B6011Q38237316-FB8482A3-7818-43BB-A9CB-20E03B54DBA2Q38259295-1E5D783A-B88E-460F-BB74-BD83BDAD9E85Q38521636-8D688FF0-E8E6-4B9E-A3DA-DD820DD884AEQ38541188-7682D29A-4AA8-4FC6-89E6-1F2EDA1001B3Q38746275-FAB14CB0-62F1-4CAD-9609-59431CF6FB37Q40184667-5FEF798D-607B-40F5-834C-57E9219A0395
P2860
Hypersensitivity to oxaliplatin: clinical features and risk factors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@en
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@nl
type
label
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@en
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@nl
prefLabel
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@en
Hypersensitivity to oxaliplatin: clinical features and risk factors.
@nl
P2093
P2860
P50
P356
P1476
Hypersensitivity to oxaliplatin: clinical features and risk factors
@en
P2093
Benoit You
Catherine Rioufol
Chloé Gourc
Céline Alloux
Eléna Kiouris
Florence Ranchon
Gilles Freyer
Marie Parel
Marie-Gabrielle Guedat
Nicolas Vantard
P2860
P2888
P356
10.1186/2050-6511-15-1
P577
2014-01-13T00:00:00Z
P5875
P6179
1029123532